PlusLife’s objective is to provide high class donated bone and tissue allografts to clinicians, to enable the surgical treatment of a wide range of problems.
Our priority is to service demand for bone and tissue grafts primarily used in Western Australia; however, we also distribute graft material to other Australian states to support demand; and is some instances to New Zealand and South East Asia. Export approval is obtained from the Commonwealth for any overseas distribution.
Pluslife has built a new state-of-the-art facility in Midland. Our new home is in close proximity to the new Midland health precinct which includes St John of God Public and Private Hospitals, the planned Curtin University Medical School, a GP super-clinic, and allied health professionals. The recently completed extension houses a cleanroom suite, an in-house tissue testing lab, dedicated research laboratory and our graft freezers.
We look forward to collaboration with Western Australian researchers in developing more highly advanced allografts.
Our processing methods involve a number of steps to produce allografts which are fit for purpose. Constant monitoring of our C class cleanroom environment and sampling of tissue throughout the process enables us to provide assurance that the tissue we produce is of a high standard. All processed graft is irradiated prior to distribution.
- Donated in Australia. Processed in Australia
- Fully recoverable by health funds
- Screened and processed in accordance with Therapeutic Goods Administration regulations - % ARTG ID 229915
- Available for many applications
Donor Sourcing and Screening
PlusLife adheres to strict exclusion criteria and regulatory controls for screening and testing mandated by the Therapeutic Goods Administration thus minimising the risk of the transmission of disease and ensuring the safety of recipients.
Deceased (Cadaveric program) and Living (Femoral Head program) Donors are tested for a range of infectious diseases including Hepatitis B & C, HIV (AIDS) and Syphilis. Microbiology and histopathology testing is also conducted on donor samples.
Constant monitoring of our C grade cleanroom environment and sampling of tissue throughout processing enables us to provide assurance that the tissue we produce is of a high standard.
All processed allograft is terminally irradiated(25kGy) prior to distribution. Tendons undergo low dose irradiation of 15kGy.
At PlusLife, each Allograft is produced from a single donor to ensure complete traceability. We do not practice donor pooling.
For Medical Professionals
PlusLife has a wide range of musculoskeletal tissue allografts available.
We can provide high resolution photographs of most allografts (taken at processing) along with accurate measurements to ensure the allograft meets your needs. Please note that these photos are taken prior to irradiation. Annotated X- rays are also available to be sent electronically.
Our Technicians are available 24/7 to assist Medical Professionals and hospital staff with questions regarding ordering and distribution of our graft.
Please find the following documents under LATEST CLINICAL NEWS & FORMS
- PlusLife Allograft Catalogue
- Patient Information Brochure for Receiving a Bone Graft
- Allograft Order Form(Form E)
- 3.2 Interstate/Overseas Allograft Order Form
Research & Development
Our new Midland facility will enable us to collaborate with clinicians & researchers in developing more highly advanced allografts which meet and exceed clinical expectations; therefore we welcome clinical input and the opportunity to discuss research & development collaborations.
For inquiries, please contact our Business Development Manager Nadine Liechti on: